Mealey's (May 29, 2019, 11:36 AM EDT) -- WILMINGTON, Del. — A federal judge in Delaware on May 28 ruled that patent infringement allegations stemming from an application to make generic “Abraxane” should be heard in Delaware, not California (Abraxis Bioscience LLC, et al. v. HBT Labs Inc., No. 18-2019, D. Del., 2019 U.S. Dist. LEXIS 88752)....